Analyst Ratings for Caris Life Sciences Inc (CAI)

CAI Rating Summary

CAI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CAI
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $35.40 (+90.4%) * Over Last 12-Mos
Rating Score: 6.7 / 10   Percentile Rank: 71%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/17/2026 Baird
» Updated 3/2/2026
Catherine Schulte New Coverage Outperform
(N/A)
28.00
(26.00)
20.65
(18.59)
-9.98% Details
12/2/2025 Canaccord
» Updated 1/26/2026
Kyle Mikson New Coverage Hold
(N/A)
30.00
(N/A)
26.05
(18.59)
-28.64% Details